Published in Platelets on February 01, 2007
Oxidant-antioxidant balance in the blood of patients with chronic obstructive pulmonary disease after smoking cessation. Oxid Med Cell Longev (2013) 0.85
Mitochondria in lung disease. J Clin Invest (2016) 0.82
Oxidant-antioxidant status in the blood of horses with symptomatic recurrent airway obstruction (RAO). J Vet Intern Med (2014) 0.78
Modification of the fatty acid composition of the erythrocyte membrane in patients with chronic respiratory diseases. Lipids Health Dis (2013) 0.78
Arachidonic acid intake and asthma risk in children and adults: a systematic review of observational studies. J Nutr Sci (2014) 0.78
Platelet and red blood cell interactions and their role in rheumatoid arthritis. Rheumatol Int (2015) 0.75
Alterations in Serum Polyunsaturated Fatty Acids and Eicosanoids in Patients with Mild to Moderate Chronic Obstructive Pulmonary Disease (COPD). Int J Mol Sci (2016) 0.75
Influence of a moderate physical activity intervention on red cell deformability in patients suffering from chronic obstructive pulmonary disease (COPD). Wien Med Wochenschr (2013) 0.75
Reactive oxygen species: are they important for haematopoiesis? Crit Rev Oncol Hematol (2011) 0.92
Membrane cholesterol contents influence the protective effects of quercetin and rutin in erythrocytes damaged by oxidative stress. Chem Biol Interact (2006) 0.86
Membrane cholesterol in the regulation of aminophospholipid asymmetry and phagocytosis in oxidized erythrocytes. Free Radic Biol Med (2007) 0.82
Increase in vulnerability to oxidative damage in cholesterol-modified erythrocytes exposed to t-BuOOH. Biochim Biophys Acta (2005) 0.82
Changes in the expression and dynamics of SHP-1 and SHP-2 during cerulein-induced acute pancreatitis in rats. Biochim Biophys Acta (2008) 0.82
Platelet linoleic acid is a potential biomarker of advanced non-small cell lung cancer. Exp Mol Pathol (2009) 0.81
Structural characteristics of a lipid peroxidation product, trans-2-nonenal, that favour inhibition of membrane-associated phosphotyrosine phosphatase activity. Biochim Biophys Acta (2005) 0.80
Comparative antioxidant capacities of quercetin and butylated hydroxyanisole in cholesterol-modified erythrocytes damaged by tert-butylhydroperoxide. Food Chem Toxicol (2011) 0.79
Alterations in erythrocyte membrane protein composition in advanced non-small cell lung cancer. Blood Cells Mol Dis (2006) 0.79
Comparison of changes in erythrocyte and platelet fatty acid composition and protein oxidation in advanced non-small cell lung cancer. Cancer Invest (2006) 0.79
Rolipram and SP600125 suppress the early increase in PTP1B expression during cerulein-induced pancreatitis in rats. Pancreas (2010) 0.78
Membrane cholesterol contents modify the protective effects of quercetin and rutin on integrity and cellular viability in oxidized erythrocytes. Free Radic Biol Med (2010) 0.78
Erythrocyte and platelet phospholipid fatty acids as markers of advanced non-small cell lung cancer: comparison with serum levels of sialic acid, TPS and Cyfra 21-1. Cancer Invest (2008) 0.77
Proteomic analysis of the soluble and the lysosomal+mitochondrial fractions from rat pancreas: Implications for cerulein-induced acute pancreatitis. Biochim Biophys Acta (2012) 0.76
CDDO-Im, an antitumor molecule that also improves platetet production. Leuk Res (2010) 0.76
Identification of potential erythrocyte phospholipid fatty acid biomarkers of advanced lung adenocarcinoma, squamous cell lung carcinoma, and small cell lung cancer. Tumour Biol (2015) 0.76
Acute pancreatitis decreases pancreas phospholipid levels and increases susceptibility to lipid peroxidation in rat pancreas. Lipids (2002) 0.75
Changes in the morphology and lability of lysosomal subpopulations in caerulein-induced acute pancreatitis. Dig Liver Dis (2010) 0.75